Barclays analyst Saket Kalia raised the firm’s price target on Alkami (ALKT) to $41 from $35 and keeps an Equal Weight rating on the shares. The firm says the company’s Q3 annual recurring revenue was better than estimates driven new customers and add-on sales gaining more steam.